Itron (NASDAQ:ITRI – Get Free Report) had its price target boosted by research analysts at JPMorgan Chase & Co. from $145.00 to $155.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 18.02% from the stock’s current price.
Other equities research analysts have also recently issued research reports about the company. Roth Capital raised their price objective on Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. Johnson Rice cut Itron from a “buy” rating to an “accumulate” rating in a report on Friday, August 1st. Weiss Ratings restated a “buy (b)” rating on shares of Itron in a report on Wednesday, October 8th. Stephens restated an “equal weight” rating and set a $130.00 price objective on shares of Itron in a report on Tuesday, October 7th. Finally, Zacks Research upgraded Itron from a “hold” rating to a “strong-buy” rating in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $138.10.
Get Our Latest Research Report on Itron
Itron Stock Performance
Itron (NASDAQ:ITRI – Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business had revenue of $606.76 million for the quarter, compared to analysts’ expectations of $610.36 million. During the same quarter last year, the firm earned $1.21 earnings per share. The business’s revenue was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, analysts anticipate that Itron will post 5.33 EPS for the current fiscal year.
Insider Activity at Itron
In other Itron news, SVP Donald L. Reeves III sold 547 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $68,544.57. Following the transaction, the senior vice president owned 19,604 shares in the company, valued at $2,456,577.24. The trade was a 2.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Christopher E. Ware sold 351 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $43,983.81. Following the transaction, the senior vice president owned 19,117 shares in the company, valued at approximately $2,395,551.27. This represents a 1.80% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 3,037 shares of company stock valued at $380,566 over the last 90 days. Corporate insiders own 1.45% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. Twin Peaks Wealth Advisors LLC acquired a new position in shares of Itron during the second quarter worth about $30,000. Bessemer Group Inc. lifted its stake in shares of Itron by 125.7% during the second quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock worth $34,000 after purchasing an additional 142 shares in the last quarter. Wayfinding Financial LLC acquired a new position in shares of Itron during the first quarter worth about $45,000. Northwestern Mutual Wealth Management Co. increased its position in shares of Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after acquiring an additional 268 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after acquiring an additional 81 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.
About Itron
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Further Reading
- Five stocks we like better than Itron
- What is the Dogs of the Dow Strategy? Overview and Examples
- This AI Chip Giant Could Be the Market’s Next Big Winner
- Stock Sentiment Analysis: How it Works
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.